Last updated on February 2020

A Study to Evaluate the Efficacy and Safety of Pemigatinib Versus Chemotherapy in Unresectable or Metastatic Cholangiocarcinoma - (FIGHT-302)

Brief description of study

The purpose of this study is to evaluate the efficacy and safety of pemigatinib versus gemcitabine plus cisplatin chemotherapy in first-line treatment of participants with unresectable or metastatic cholangiocarcinoma with FGFR2 rearrangement.


Clinical Study Identifier: TX218088

Find a site near you

Start Over

Kindai University Hospital

Located in: Osakasayama City, Japan
  Connect »